BACKGROUND The optimal antiretroviral treatment for patients who have human immunodeficiency virus (HIV) viremia despite treatment with nucleoside reverse-transcriptase inhibitors (nucleoside analogues) remains uncertain. We studied treatment with regimens that combined two nucleoside analogues, at least one of which was new, with the protease inhibitor nelfinavir, the nonnucleoside reverse-tra...

A 64 year old male patient suffering from Crohn's disease received infliximab therapy for a period of 5 months prior to presentation to our hospital. Due to the symptoms fever, ascites, and diffuse abdominal tenderness on palpation of unknown origin, a CT scan of the abdomen was performed and led to the suspected diagnosis of a peritoneal carcinomatosis. QuantiFERON™ test revealed a tuberculosi...

METHODS: Patients with active Helicobacter pylori infection at four medical centers received proton pump inhibitorbased triple or quadruple therapy for 10–14 days. Patients underwent the C-UBT 2 and 4–6 wk after the completion of therapy. A positive test was defined as CO2 excretion of .200 dpm, a negative test as ,50 dpm, and an equivocal test as .50 but ,200 dpm. Performance characteristics o...

Helicobacter pylori (H. Pylori) is one of the most common infectious human pathogens. H. could induce inflammation, that causes illnesses and disorders upper gastrointestinal which including peptic ulcer diseases, dyspepsia, gastroesophageal reflux disease gastric mucosa-associated lymphoid tissue (MALT) lymphoma. It important to use a better tolerated greatly effective eradication regimen. In ...

BACKGROUND Eradication of Helicobacter pylori infection has had an impact on the treatment and recurrence rates of peptic ulcer disease and malignancies such as mucosa-associated lymphoid tissue lymphoma. Treatment options are cumbersome, expensive, and associated with side effects. METHODS Randomized, prospective, open-labeled equivalence trial with a parallel-group design to compare eradica...

Correspondence to: Battal Altun Department of Internal Medicine, Kasımpasa Military Hospital, Yesilkoy, Istanbul 34149, Turkey Tel: +90-5415429657, E-mail: [email protected] Received on November 30, 2014. Revised on January 6, 2015. Accepted on January 7, 2015. Published online June 19, 2015 pISSN 1976-2283 eISSN 2005-1212 http://dx.doi.org/10.5009/gnl14469 To the Editor: We read the articl...